SYN - I will be hanging on. Will be a good run starting April. Other than recent Financial Report (Pertussis (Whooping Cough) – Monoclonal Antibody (mAb))
Synthetic Biologics Reports Year End 2013 Financial Results and Operational Update
ROCKVILLE, Md., March 31, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other diseases, today reported financial results for the year ended December 31, 2013 and provided operational highlights.